Skin Cancer

Biomarker for immune checkpoint blockade sensitivity in Merkel cell carcinoma identified

A new study published in Cancer Discovery suggests that Merkel cell carcinoma patients with higher levels of preexisting tissue-resident...

New radiation therapy guidelines for non-melanoma skin cancer

The Dermatology Association of Radiation Therapy (DART), a U.S. national non-profit medical society, has published new clinical...

Social determinants of health amply rural/urban discrepancies in skin cancer

Residents of U.S. rural areas continue to have an elevated risk of skin cancer compared to their urban counterparts, and these...

Public confidence in skin cancer self-examination as a target for education

Findings from two recent studies suggest that an individual’s lack of confidence in their ability to self-examine for skin cancer may be...

Inherited gene mutations raise melanoma risk more than thought, study finds

Sun exposure has long been viewed as the primary risk factor for skin cancer, with inherited genes playing a relatively minor role. But a...

Plasma biomarker may identify response to PD-1 inhibitor Tx for melanoma

In a new study, researchers have discovered that a specific liquid biopsy biomarker could potentially be used to assess the effectiveness...

Melanoma vaccine enters international trial phase

Phase III studies of a personalized vaccine plus immunotherapy for melanoma have been launched at cancer centres around the world,...

Modulating the gut microbiome may improve response to ICB therapy

Deciphering and modifying the composition of various gut bacteria may improve immune checkpoint blockade (ICB) treatment responses in...

1

Featured Posts